SIRT6 in Longevity and Progeria
Current understanding
SIRT6 is a chromatin-associated sirtuin with deacetylase, mono-ADP-ribosyltransferase, and defatty-acylase activities implicated in DNA repair, heterochromatin maintenance, and metabolic regulation; loss-of-function shortens mouse lifespan while transgenic overexpression extends it (animal-model). Ashkenazi centenarian-enriched SIRT6 missense variants (e.g., N308K/A313S) raise endogenous SIRT6 protein and rebalance its enzymatic activities, and knock-in of these variants in hESC-derived lineages enhances resistance to cellular senescence and progerin stress, with partial phenocopy by AAV-SIRT6 or fucoidan-derived activators in progeria fibroblasts (mechanism-plausible for humans; preclinical). No human outcome data yet — the translation pitch (SIRT6 activator therapeutics for progeria/aging) currently outruns the biology.
Evidence log
- 2026-07-01 — AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.: cross-connection with nuclear-lamina-progerin: Both pages now converge on progeroid biology from opposite ends: SIRT6 centenarian variants confer intrinsic progerin-stress resistance, while LM2556 directly depletes progerin transcripts — complementary upstream and downstream levers on the same laminopathy axis. (novelty: 4)
- 2026-08-05 — Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.: 2026 hepatocyte-specific Sirt6-KO mouse study: liver SIRT6 loss shortens female median lifespan ~17.6% and drives gerometabolic decline via SULT1E1-mediated estrogen sulfation/depletion, and the SIRT6 activator MDL-800 restores estrogen homeostasis and rescues aged-female phenotypes — extends SIRT6 longevity biology to a sex-specific hepatic–endocrine axis with a small-molecule activator handle, still preclinical. [animal-model] (novelty: 3)
- 2026-06-19 — Centenarian SIRT6 variants elevate SIRT6 protein and enhance cellular senescence resistance.: cross-connection with comparative-longevity: Ashkenazi centenarian SIRT6 variants provide a within-human comparative-longevity genetic signal that converges with cross-species SIRT6-dosage lifespan effects, connecting human longevity genetics to comparative sirtuin biology. (novelty: 4)